ERBB2 (HER2) Testing in Breast Cancer

被引：5
|
作者：
Hilal, Talal [1 ]
Romond, Edward H. [2 ]
机构：
[1] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Div Med Oncol, Lexington, KY 40536 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 12期
关键词：
NCCTG N9831; SURVIVAL;
D O I：
10.1001/jama.2015.17463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1281
页数：2
相关论文
共 50 条
  • [21] Identification of autocrine motility factor (AMF) receptor, HER2 (ErbB2) in breast cancer cells
    Kho, Dhonghyo
    CANCER RESEARCH, 2012, 72
  • [22] Munich Based Breast Cancer Symposium ErbB2(HER2)-positive metastatic Breast Cancer: The use of therapeutic Options
    Pohlmann, Birgit-Kristin
    BREAST CARE, 2012, 7 (01) : 74 - 77
  • [23] The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer
    Lippa, Blaise
    Kauffman, Goss S.
    Arcari, Joel
    Kwan, Tricia
    Chen, Jinshan
    Hungerford, William
    Bhattacharya, Samit
    Zhao, Xumiao
    Williams, Courtney
    Xiao, Jun
    Pustilnik, Leslie
    Su, Chunyan
    Moyer, James D.
    Ma, Ling
    Campbell, Mary
    Steyn, Stefanus
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 3081 - 3086
  • [24] Testing for HER2 in breast cancer
    Lewis, F
    Jackson, P
    Lane, S
    Coast, G
    Hanby, AM
    HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
  • [25] HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
    Prat, Aleix
    Pascual, Tomas
    De Angelis, Carmine
    Gutierrez, Carolina
    Llombart-Cussac, Antonio
    Wang, Tao
    Cortes, Javier
    Rexer, Brent
    Pare, Laia
    Forero, Andres
    Wolff, Antonio C.
    Morales, Serafin
    Adamo, Barbara
    Braso-Maristany, Fara
    Vidal, Maria
    Veeraraghavan, Jamunarani
    Krop, Ian
    Galvan, Patricia
    Pavlick, Anne C.
    Bermejo, Begona
    Izquierdo, Miguel
    Rodrik-Outmezguine, Vanessa
    Reis-Filho, Jorge S.
    Hilsenbeck, Susan G.
    Oliveira, Mafalda
    Vittoria Dieci, Maria
    Griguolo, Gaia
    Fasani, Roberta
    Nuciforo, Paolo
    Parker, Joel S.
    Conte, PierFranco
    Schiff, Rachel
    Guarneri, Valentina
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (01): : 46 - 54
  • [26] ERBB2 (HER2) protein expression in uterine sarcomas
    Zafrakas, M.
    Zepiridis, L.
    Theodoridis, T. D.
    Venizelos, I. D.
    Papanicolaou, A.
    Agorastos, T.
    Bontis, J. N.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (03) : 292 - 294
  • [27] ERBB2 (HER2) Mutation Spectrum in Solid Tumors
    Wen, W.
    Chen, W.
    Millis, S.
    Bender, R.
    Ghazalpour, A.
    Tan, Z.
    Basu, G.
    Gatalica, Z.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 917 - 917
  • [28] Acral lentiginous melanoma with HER2/ErbB2 amplification
    Marie Donzel
    Olivier Harou
    François Skowron
    Stéphane Dalle
    Françoise Descotes
    Brigitte Balme
    Jonathan Lopez
    European Journal of Dermatology, 2021, 31 : 588 - 590
  • [29] HER2/ErbB2 signals through Plexin-B1 to promote breast cancer metastasis
    Worzfeld, T.
    Swiercz, J.
    Looso, M.
    Straub, B.
    Offermanns, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 3 - 3
  • [30] Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
    Schroeder, Richard L.
    Stevens, Cheryl L.
    Sridhar, Jayalakshmi
    MOLECULES, 2014, 19 (09) : 15196 - 15212
12345